A 3D rendering of an antibody (foreground left), and examples of high-priority &quotprototype&quot pathogens that have the potential to threaten human health/are the focus of pandemic preparedness research efforts (left to right): hantavirus, yellow fever virus, Nipah virus, picornavirus, and Chikungunya. As of September 2024, The National Institutes of Health (NIH) has established a pandemic preparedness research network known as ReVAMPP to conduct research on high-priority pathogens with the goal of developing effective vaccines and monoclonal antibodies. Credit: NIAID See related September 13, 2024 NIAID news release, &quotNIH Awards Establish Pandemic Preparedness Research Network,&quot at.

A 3D rendering of an antibody (foreground left), and examples of high-priority &quotprototype&quot pathogens that have the potential to threaten human health/are the focus of pandemic preparedness research efforts (left to right): hantavirus, yellow fever virus, Nipah virus, picornavirus, and Chikungunya. As of September 2024, The National Institutes of Health (NIH) has established a pandemic preparedness research network known as ReVAMPP to conduct research on high-priority pathogens with the goal of developing effective vaccines and monoclonal antibodies. Credit: NIAID See related September 13, 2024 NIAID news release, &quotNIH Awards Establish Pandemic Preparedness Research Network,&quot at.
SuperStock offers millions of photos, videos, and stock assets to creatives around the world. This image of A 3D rendering of an antibody (foreground left), and examples of high-priority &quotprototype&quot pathogens that have the potential to threaten human health/are the focus of pandemic preparedness research efforts (left to right): hantavirus, yellow fever virus, Nipah virus, picornavirus, and Chikungunya. As of September 2024, The National Institutes of Health (NIH) has established a pandemic preparedness research network known as ReVAMPP to conduct research on high-priority pathogens with the goal of developing effective vaccines and monoclonal antibodies. Credit: NIAID See related September 13, 2024 NIAID news release, &quotNIH Awards Establish Pandemic Preparedness Research Network,&quot at. by NIH-NIAID/IMAGE POINT FR/BSIP is available for licensing today.
$24.99
Personal Use
Personal Print and non commercial wall décor use. Not for re-sale.
$99.00
Website
Single non-exclusive Website, App, social media and blog use, for 5 years. Excludes Advertising.
$225.00
Magazines / Books / Educational
Non-exclusive Magazine, Book or Educational use, both print and digital, in any language. Worldwide in Perpetuity. Does not include cover use.
$300.00
Marketing Bundle
Single non exclusive use in a marketing campaign, worldwide (excludes advertising). Only available to companies with up to 20 employees for 5 years.
$440.00
Advertising Pack
Single Non exclusive use in Advertising Campaign up to 50,000 and digital copies, includes: brochure, catalog, flyer, newsletter, and other collateral printed pieces + web usage. Worldwide for 5 years.
  • Download your images from the download tab on this page after purchase.
  • Up to 3 downloads
  • Can be used for 365 days after purchase.
$59.99
RM Personal Print 3 Pack
Save $14.98
$20.00
per download
Order a Framed Print
Looking for a license?
Click here, and we'll help you find it! Questions? Just ask!
DETAILS
Image Number: 824-66066020Rights ManagedCredit Line:NIH-NIAID/IMAGE POINT FR/BSIP/SuperStockCollection:BSIPContributor:NIH-NIAID / IMAGE POINT FR / BSIPModel Release:NoProperty Release:NoResolution:3883×3020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|